Our CEO and co-founder, Matteo Cornaglia, speaks today about the future of New Approach Methodologies and how Nagi Bioscience is fulfilling this market need in an interview for Verve Ventures.
Radio Télévision Suisse consulted our co-founder and CSO Laurent Mouchiroud about today’s advances in the field of aging and longevity research for the monthly health reportage.
From drug discovery to a possible future tool for lung cancer detection. How the Worm-on-chip is revolutionizing the alternative testing methods sector.
